Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Catalyst Grant: Post Market Drug Safety and Effectiveness

McMaster University

$99,025.00

A National Electronic Network for Rapid Assessment of Drug Safety and Effectiveness

FY 2009-10

Summary
The stated priority of the CIHR Drug Safety and Effectiveness catalyst grant call is to stimulate collaboration among researchers to generate innovative tools and methodologies to reduce gaps in real-world drug safety and effectiveness (DSE) knowledge. Our proposal seeks to investigate the relative effect of individual NSAIDs on gastrointestinal (GI) side effects using a novel electronic network which is anchored in Canadian primary care. A cohort with nested case control design is proposed, with additional analyses to test current innovation in research methods. Our hypothesis is that, once equivalent doses are taken into account, that there are not major differences between individual NSAIDs in terms of their overall GI safety. Electronic medical records (EMRs) are a new data resource, are widely promoted as a tool to transform healthcare, yet have never been adequately evaluated for their impact on health care services and outcomes. Similarly the NSAID family of drugs is one of the most heavily used worldwide, has more than 20 drug members, is thought to cause considerable harm, yet has not been adequately evaluated in terms of the individual NSAIDs and their association with adverse GI events. Our team collectively has developed a unique national primary care-based EMR network database with anonymous patient information. We also have amongst us decades of experience working on drug safety and effectiveness studies and their translation to practice and policy, analyzing large datasets, evaluating EMR data, and evaluating the quality of research methods. The lessons learned from this initial feasibility study will assist us in planning a larger drug safety and effectiveness network proposal.
Program
Catalyst Grant: Post Market Drug Safety and Effectiveness
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
192722
Name
Holbrook Anne M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Catalyst Grant: Post Market Drug Safety and Effectiveness
Projecttitle
A National Electronic Network for Rapid Assessment of Drug Safety and Effectiveness
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$99,025
Cihrequipment2
$0
Programname2
Catalyst Grant: Post Market Drug Safety and Effectiveness
Keyworddelim
Bias Correction; Electronic Medical Records; Gastrointestinal Complications; Nonsteroidal Antiinflammatory Drugs; Observational Methods; Pharmacosurveillance
Abstract
The stated priority of the CIHR Drug Safety and Effectiveness catalyst grant call is to stimulate collaboration among researchers to generate innovative tools and methodologies to reduce gaps in real-world drug safety and effectiveness (DSE) knowledge. Our proposal seeks to investigate the relative effect of individual NSAIDs on gastrointestinal (GI) side effects using a novel electronic network which is anchored in Canadian primary care. A cohort with nested case control design is proposed, with additional analyses to test current innovation in research methods. Our hypothesis is that, once equivalent doses are taken into account, that there are not major differences between individual NSAIDs in terms of their overall GI safety. Electronic medical records (EMRs) are a new data resource, are widely promoted as a tool to transform healthcare, yet have never been adequately evaluated for their impact on health care services and outcomes. Similarly the NSAID family of drugs is one of the most heavily used worldwide, has more than 20 drug members, is thought to cause considerable harm, yet has not been adequately evaluated in terms of the individual NSAIDs and their association with adverse GI events. Our team collectively has developed a unique national primary care-based EMR network database with anonymous patient information. We also have amongst us decades of experience working on drug safety and effectiveness studies and their translation to practice and policy, analyzing large datasets, evaluating EMR data, and evaluating the quality of research methods. The lessons learned from this initial feasibility study will assist us in planning a larger drug safety and effectiveness network proposal.
Competitiondate
200910
Approvedterm2
1 yr 0 mth
Pinamesdelim
Holbrook, Anne M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $99,025~ $0~
McMaster University - $99,025 Grant (2009-10) | Canada Spends